Schwarzenegger to Inspire a Bold New Era of Well-being, Active Living and Reinvention to Advance Company's Mission to Alleviate Pain and Improve the Quality of Life for People Around the World WARSAW, Ind. , Nov. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a partnership with Arnold Schwarzenegger , who will take on the newly established role... Read More

WARSAW, Ind. , Nov. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Jefferies London Healthcare Conference on November 19, 2024 , with a fireside chat at 11:00 a.m. GMT ( 6:00 a.m. ET ). A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at... Read More

Third quarter net sales of $1.824 billion increased 4.0% and 4.1% on a constant currency 1 basis Third quarter diluted earnings per share were $1.23 ; adjusted 1 diluted earnings per share were $1.74 Company updates 2024 financial guidance, reducing and narrowing range for full year outlook WARSAW, Ind. , Oct. 30, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the... Read More

Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies Including OrthoGrid Hip AI ® and HAMMR™ Automated Hip Impaction System WARSAW, Ind. , Oct. 28, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced plans for the broad commercial launch of the Z1™ Femoral Hip System (Z1 System) for total hip arthroplasty at the 2024 annual... Read More

DURHAM, N.C. and WARSAW, Ind. , June 12, 2024 /PRNewswire/ -- RevelAi Health and Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a multi-year co-marketing agreement to commercialize generative artificial intelligence (AI)-powered engagement solutions that advance value-based orthopedic care and health equity. During the multi-year agreement, Zimmer Biomet will... Read More

WARSAW, Ind. , Dec. 14, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of its Executive Management Team are scheduled to present at the Goldman Sachs CEOs Unscripted Conference on Thursday, January 5, 2023 , at 11:25 a.m. ET and at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 , at 3:45 p.m. PT / 6:45... Read More